Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proposed subtypes of post‐COVID‐19 syndrome (or long‐COVID) and their respective potential therapies
Shin Jie Yong, Shiliang Liu
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Pathophysiology and mechanism of long COVID: a comprehensive review
Diego Castanares‐Zapatero, Patrice Chalon, Laurence Kohn, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1473-1487
Open Access | Times Cited: 444
Postural orthostatic tachycardia syndrome as a sequela of COVID-19
Cameron K. Ormiston, Iwona Świątkiewicz, Pam R. Taub
Heart Rhythm (2022) Vol. 19, Iss. 11, pp. 1880-1889
Open Access | Times Cited: 101
Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial
Shani Zilberman-Itskovich, Merav Catalogna, Efrat Sasson, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 91
Inflammatory and vascular biomarkers in post‐COVID‐19 syndrome: A systematic review and meta‐analysis of over 20 biomarkers
Shin Jie Yong, Alice Halim, Michael Halim, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 80
COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 78
A systematic review and meta‐analysis of long‐term sequelae of COVID‐19 2‐year after SARS‐CoV‐2 infection: A call to action for neurological, physical, and psychological sciences
Masoud Rahmati, Raphael Udeh, Dong Keon Yon, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 73
Multi-organ impairment and long COVID: a 1-year prospective, longitudinal cohort study
Andrea Dennis, Daniel J. Cuthbertson, Dan Wootton, et al.
Journal of the Royal Society of Medicine (2023) Vol. 116, Iss. 3, pp. 97-112
Open Access | Times Cited: 64
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
Jingwei Li, Yun Zhou, Jiechao Ma, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 57
Profiling post-COVID-19 condition across different variants of SARS-CoV-2: a prospective longitudinal study in unvaccinated wild-type, unvaccinated alpha-variant, and vaccinated delta-variant populations
Liane S. Canas, Erika Molteni, Jie Deng, et al.
The Lancet Digital Health (2023) Vol. 5, Iss. 7, pp. e421-e434
Open Access | Times Cited: 41
Post-COVID dysautonomias: what we know and (mainly) what we don’t know
David S. Goldstein
Nature Reviews Neurology (2024) Vol. 20, Iss. 2, pp. 99-113
Closed Access | Times Cited: 17
Mitochondrial Dysfunction and Coenzyme Q10 Supplementation in Post-Viral Fatigue Syndrome: An Overview
David Mantle, Iain P. Hargreaves, Joan Carles Domingo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 574-574
Open Access | Times Cited: 16
Low Cardiorespiratory Fitness Post-COVID-19: A Narrative Review
Fabian Schwendinger, Raphael Knaier, Thomas Radtke, et al.
Sports Medicine (2022) Vol. 53, Iss. 1, pp. 51-74
Open Access | Times Cited: 57
The potential role of ischaemia–reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications
Douglas B. Kell, Etheresia Pretorius
Biochemical Journal (2022) Vol. 479, Iss. 16, pp. 1653-1708
Open Access | Times Cited: 52
Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: A prospective observational cohort study
Anneke Haddad, Aleš Janda, Hanna Renk, et al.
EBioMedicine (2022) Vol. 84, pp. 104245-104245
Open Access | Times Cited: 41
Plasma proteome of Long-COVID patients indicates HIF-mediated vasculo-proliferative disease with impact on brain and heart function
Cristiana Iosef, Michael J. Knauer, Michael Nicholson, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 32
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Farigol Hakem Zadeh, Daniel R. Wilson, Devendra K. Agrawal
Archives of Microbiology & Immunology (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 26
Consistency of inconsistency in long‐COVID‐19 pain symptoms persistency: A systematic review and meta‐analysis
Oleg Kerzhner, Einat Berla, Meirav Har‐Even, et al.
Pain Practice (2023) Vol. 24, Iss. 1, pp. 120-159
Open Access | Times Cited: 24
Cognitive-behavioral therapy for patients with post-COVID-19 condition (CBT-PCC): a feasibility trial
D. A. Huth, Anne‐Kathrin Bräscher, Sarah Tholl, et al.
Psychological Medicine (2023) Vol. 54, Iss. 6, pp. 1122-1132
Open Access | Times Cited: 22
COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead, Stephanie Seneff, Russ Wolfinger, et al.
Cureus (2024)
Open Access | Times Cited: 13
Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID
Douglas B. Kell, Asad Khan, Binita Kane, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 170-170
Open Access | Times Cited: 8
Sulodexide Significantly Improves Endothelial Dysfunction and Alleviates Chest Pain and Palpitations in Patients With Long-COVID-19: Insights From TUN-EndCOV Study
S. Charfeddine, Hassen Ibn Hadj Amor, Jihen Jdidi, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 36
The Pathobiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Case for Neuroglial Failure
Herbert Renz‐Polster, Marie‐Ève Tremblay, Dorothee Bienzle, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 16
Open Access | Times Cited: 31
Long Covid-19 syndrome as a fourth phase of Sars-CoV2 infection
Silvia Staffolani, Valentina Iencinella, Matteo Cimatti, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 1
Open Access | Times Cited: 29
Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients
Etianne Martini Sasso, Katsuhiko Muraki, Natalie Eaton-Fitch, et al.
Molecular Medicine (2022) Vol. 28, Iss. 1
Open Access | Times Cited: 27
Luteolin-rich fraction from Perilla frutescens seed meal inhibits spike glycoprotein S1 of SARS-CoV-2-induced NLRP3 inflammasome lung cell inflammation via regulation of JAK1/STAT3 pathway: A potential anti-inflammatory compound against inflammation-induced long-COVID
Sivamoke Dissook, Sonthaya Umsumarng, Sariya Mapoung, et al.
Frontiers in Medicine (2023) Vol. 9
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top